Your browser doesn't support javascript.
loading
The impact of lungs from diabetic donors on lung transplant recipients†.
Ambur, Vishnu; Taghavi, Sharven; Jayarajan, Senthil; Kadakia, Sagar; Zhao, Huaqing; Gomez-Abraham, Jesus; Toyoda, Yoshiya.
Afiliación
  • Ambur V; Department of Surgery, Temple University Hospital, Philadelphia, PA, USA.
  • Taghavi S; Department of Surgery, Washington University in St. Louis, St. Louis, MO, USA.
  • Jayarajan S; Department of Surgery, Washington University in St. Louis, St. Louis, MO, USA.
  • Kadakia S; Department of Surgery, Temple University Hospital, Philadelphia, PA, USA.
  • Zhao H; Department of Biostatistics, Temple University School of Medicine, Philadelphia, PA, USA.
  • Gomez-Abraham J; Department of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA, USA.
  • Toyoda Y; Department of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA, USA.
Eur J Cardiothorac Surg ; 51(2): 285-290, 2017 02 01.
Article en En | MEDLINE | ID: mdl-28186285
ABSTRACT

OBJECTIVES:

We attempted to determine if transplants of lungs from diabetic donors (DDs) is associated with increased mortality of recipients in the modern era of the lung allocation score (LAS).

METHODS:

The United Network for Organ Sharing (UNOS) database was queried for all adult lung transplant recipients from 2006 to 2014. Patients receiving a lung from a DD were compared to those receiving a transplant from a non-DD. Multivariate Cox regression analysis using variables associated with mortality was used to examine survival.

RESULTS:

A total of 13 159 adult lung transplants were performed between January 2006 and June 2014 4278 (32.5%) were single-lung transplants (SLT) and 8881 (67.5%) were double-lung transplants (DLT). The log-rank test demonstrated a lower median survival in the DD group (5.6 vs 5.0 years, P = 0.003). We performed additional analysis by dividing this initial cohort into two cohorts by transplant type. On multivariate analysis, receiving an SLT from a DD was associated with increased mortality (HR 1.28, 95% CI 1.07­1.54, P = 0.011). Interestingly, multivariate analysis demonstrated no difference in mortality rates for patients receiving a DLT from a DD (HR 1.12, 95% CI 0.97­1.30, P = 0.14).

CONCLUSIONS:

DLT with DDs can be performed safely without increased mortality, but SLT using DDs results in worse survival and post-transplant outcomes. Preference should be given to DLT when using lungs from donors with diabetes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Donantes de Tejidos / Trasplante de Pulmón / Selección de Donante / Diabetes Mellitus Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Eur J Cardiothorac Surg Asunto de la revista: CARDIOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Donantes de Tejidos / Trasplante de Pulmón / Selección de Donante / Diabetes Mellitus Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Eur J Cardiothorac Surg Asunto de la revista: CARDIOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos